Regeneron shares new details on late-stage melanoma treatment trial
Regeneron provides new details on its late-stage trial of fianlimab combo therapy for previously untreated, unresectable or metastatic melanoma patients.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Hubs
Briefings
More story pages
Japan's Kissei recommends pausing Amgen's drug Tavneos amid global scrutiny
Japanese drugmaker Kissei recommends doctors stop prescribing Amgen's drug Tavneos due to global regulatory scrutiny.
California's mushroom poisoning outbreak now largest in U.S. history - 4 dead, 43 hospitalized.
California's mushroom poisoning outbreak is now the largest in U.S. history, with four deaths and 43 hospitalizations.
Uganda confirms imported Ebola case in Kampala after Congolese man dies. Ministry activates emergency screening at borders.
Uganda's Ministry of Health confirmed an imported Ebola Bundibugyo case after a Congolese man died in Kampala. The ministry has activated emergency response measures, including screening at border points.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.